ColdZyme Distribution Deal for Iraq and Jordan
Enzymatica AB from Sweden signed an exclusive long-term distribution deal with MedonyX. MedonyX is supported by the Jordanian firm MMDS. The agreement covers the registration, marketing, sale, and distribution of ColdZyme mouth spray in Jordan and Iraq. The product is expected to launch in these markets in the first quarter of 2027.
By John Lee. Sweden's Enzymatica AB has signed a long-term exclusive distribution agreement with MedonyX, a company backed by Jordanian healthcare and market-access firm MMDS, for the registration, marketing, sale and distribution of its ColdZyme mouth spray in Jordan and Iraq. Launch in both markets is expected in the first quarter of 2027, subject to […] The post ColdZyme Distribution Deal for Iraq and Jordan first appeared on Iraq Business News .